Brought to you by Portland Press Ltd.
Published on behalf of the International Federation for Cell Biology
Cancer Cell death Cell cycle Cytoskeleton Exo/endocytosis Differentiation Division Organelles Signalling Stem cells Trafficking

Instructions to Authors

1. Editorial policy
1.1 Journal scope
1.2 Types of paper published
1.3 Originality of papers
1.4 Authorship
1.5 Conflict of interest
1.6 Availability of materials
1.7 Cell lines
1.8 Cell Biology International Reports
2. Experimental and publishing ethics
3. Copyright policy
4. Opt2Pay
5. Journal features
5.1 Immediate Publications
5.2 Multimedia adjuncts
5.3 Supplementary data
5.4 Medline links and inter-journal linking
6. Submission of papers
7. Format of manuscript
8. Accepted papers
8.1 Tables
8.2 Figures
8.3 Mathematics
9. Contact details
10. Proofs
11. Offprints
12. Portland Press books

1. Editorial policy

1.1 Journal scope

Cell Biology International publishes easy-to-assimilate, up-to-the-minute reports of experimental findings by researchers using a wide range of the latest techniques. Promoting the aims of cell biologists world-wide, papers relating to structure and function - especially where the findings are seen in a whole cell (physiological) context - are very welcome. In covering all areas of the cell, the Journal is both appealing and accessible to a broad audience.

Original papers and reviews will be considered. If you wish to submit an unsolicited review article for consideration please send a summary of the proposed article to the Editor-in-Chief, Professor Denys Wheatley (wheatley@abdn.ac.uk) who will contact you regarding its potential suitability.

1.2 Types of paper published

  • Research Articles (usually up to 8 journal pages in length): original articles reporting experimental work on all aspects of cell biology
  • Short Communications: brief papers (4 journal pages or less) making a specific well-documented point
  • Reviews (8-10 journal pages) and Mini-reviews (2-4 journal pages, 1-2 figures/tables, 14 key references max.): state-of-the-art overviews of hot topics and developments, often commissioned
  • Hypotheses: manuscripts (8 journal pages or less) that present an original hypothesis. The article should set out a clearly identified hypothesis that can be supported by appropriate references. The article should propose what experimental work might test the hypothesis, but should not contain new data of an experimental nature unless essential.
  • Methodologies: original articles (≤8 journal pages describing experimental work using a new methodology which provide a detailed account of the protocol and results without in-depth speculation on the implications of the findings. The new protocol should not be followed up in the same communication with what amounts to a full research paper using it.
  • Commentaries: short notes or letters (no more than 1 journal page in length) commentating on papers published in the Journal

1.3 Originality of papers

Manuscripts are accepted for review with the understanding that the same work has not been published elsewhere in any language, including publication on the Internet; that it is not under consideration for publication elsewhere; that its submission for publication has been approved by all of the authors and by the institution where the work was carried out; that all persons entitled to authorship have been so named; that conflicts of interest have been declared; and that any person cited as a source of personal communication has approved such citation. Abstracts of oral or poster presentations are not considered to constitute previous publication. Preliminary communications in journals that regularly publish reports in this form will not preclude publication of a paper in Cell Biology International, provided the full paper contains additional information that justifies its publication and does not repeat the presentation of the same data. To facilitate evaluation of this matter by the Editorial Board, submitted manuscripts should be accompanied by copies of all preliminary communications and of all relevant manuscripts that are in press or under editorial consideration elsewhere.

Cell Biology International will not tolerate plagiarism in submitted manuscripts. Passages quoted or closely paraphrased from other authors (or from the submitting authors' own published work) must be identified as quotations or paraphrases, and the sources of the quoted or paraphrased material must be acknowledged. Use of unacknowledged sources will be construed as plagiarism. If any manuscript is found to contain plagiarized material the review process will be halted immediately.

1.4 Authorship

Cell Biology International endorses the Vancouver Guidelines on authorship as defined in the International Committee of Medical Journal Editors' (ICMJE) Uniform Requirements for Manuscripts Submitted to Biomedical Journals, namely that entitlement to authorship should be based on all of the following criteria: (1) substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; (2) drafting the article or revising it for important intellectual content; (3) final approval of the version to be published. Acquisition of funding, collection of data, or general supervision of the research group, alone, does not justify authorship. All contributors who do not meet the criteria for authorship should be listed in the Acknowledgements. On acceptance, a paragraph outlining the contribution of each author will be requested and published as part of the paper.

Cell Biology International follows a rigorous reviewing procedure, which, for each paper, requires written input from at least two Reviewers. In each case the Editorial Office ensures that those involved in the process act independently and have no conflict of interest in the paper. In case of a complaint, the Editorial Office, if it is deemed necessary and appropriate, may ask for additional review(s) before making a recommendation. In all cases, the final decision rests with the Editor-in-Chief. The Editorial Board reserves the right to reject papers that are unsuitable for the journal or cannot adequately be assessed because of a poor standard of English.

1.5 Conflict of interest

Authors are requested to disclose any actual or potential conflict of interest including any financial, personal or other relationships with other people or organizations within 3 years of beginning the submitted work that could inappropriately influence, or be perceived to influence, their work.

1.6 Availability of materials

Original papers must contain sufficient detail to enable others to repeat the work. Submission of a paper to Cell Biology International implies that you will make available samples of unique biological materials (including cell lines, DNA clones and antibodies) to academic workers who request them.

1.7 Cell lines

Authors must ensure that any cell lines used (1) are certified as being the designated type, (2) have been checked to ensure they are free of contamination, and (3) have been used from young stock (following the good practice outlined in the UKCCCR Guidelines for the Use of Cell Lines in Cancer Research, http://www.nature.com/bjc/journal/v82/n9/pdf/6691169a.pdf) and have included evidence of good practice in the Materials and Methods section.

1.8 Cell Biology International Reports

Cell Biology International Reports is the online-only, open-access sister journal to Cell Biology International. The Editorial Board of Cell Biology International may recommend that a paper declined for publication in Cell Biology International, but which makes a technically sound contribution to the literature, is published in Cell Biology International Reports.

2. Experimental and publishing ethics

Experiments with animals should be performed in accordance with the legal requirements of the relevant local or national authority. Procedures should be such that experimental animals do not suffer unnecessarily. The text of papers should include details of the strain or stock of animal used, experimental procedures, and of anaesthetics used. It is recommended that authors refer to the 'ARRIVE' Guidelines on the reporting of animal research.

Papers describing any experimental work with humans should include a statement that the research has been carried out in accordance with the Declaration of Helsinki (2008) (http://www.wma.net/en/20activities/10ethics/10helsinki/) of the World Medical Association, that the Ethical Committee of the Institution in which the work was performed has approved it, and that the subjects have given written informed consent to the work.

The Editorial Board will not accept papers where the ethical aspects are, in the Board's opinion, open to doubt.

Cell Biology International endorses the guidelines published by COPE (Committee on Publication Ethics; http://www.publicationethics.org/) and will always investigate fully any matters of apparent misconduct that it becomes aware of.

Cell Biology International follows the guidelines published by COPE in respect of the retraction of articles.

Cell Biology International is published by Portland Press Limited on behalf of the International Federation for Cell Biology, the sole owner of the journal. In order to allow your article to be distributed as widely as possible in the Journal we ask that you grant Portland Press Limited and the International Federation for Cell Biology an exclusive licence to publish your accepted article on behalf of the International Federation for Cell Biology. There are also a number of other reasons for this: (i) you authorize Portland Press Limited and the International Federation for Cell Biology to act to defend your copyright, although we are under no obligation to act in this way; (ii) it will enable us to deal efficiently with requests from third parties to reproduce or reprint the article, or part of it.

Ownership of copyright remains with you as the author (or with your employer if they own the copyright in the work) and you retain non-exclusive rights to do the following (provided that the Journal is acknowledged in standard bibliographic citation form):

  • use your article as long as it is not sold or given away in ways which would conflict directly with the commercial business interests of Portland Press Limted
  • reproduce your article in whole or in part in any printed work of which you are the author
  • use your article for teaching purposes within your institution, including use in course packs
  • post an electronic version (Word or PDF) of the Accepted Manuscript (AM) of your article on your website or institutional repository 6 months after the printed Journal is in the public domain, provided you give a hyperlink from the article to the Journal's website together with the following text: "The Version of Record (VoR) is available at http://www.cellbiolint.org"

You need not seek permission from Portland Press Limited and the International Federation for Cell Biology to apply the above rights.

Please note: you are NOT permitted to post the Portland Press Limited version of your article (the Version of Record, VoR) online. For definitions of journal article versions, see the Recommended Practice of the National Information Standards Organization in Partnership with the Association of Learned and Professional Society Publishers.

Full details will be provided on the Licence to Publish that you will be asked to sign when your paper is accepted for publication.

4. Opt2Pay

On acceptance authors may choose to pay a fee to make the Version of Record (VoR) of their paper freely available under the Creative Commons Attribution Non-Commercial Licence. Portland Press Limited will post all pre-paid articles on PubMed Central (PMC) on receipt of payment as a service to authors and permit their inclusion on PMC mirror sites. The Opt2Pay scheme allows authors to post the PDF version of the Version of Record (VoR), for non-commercial purposes, on their own or institutional website or to free public servers in the relevant subject area, in whole or in part according to the terms of the licence, provided they include a link to the published article on the Journal's website and that the Journal, Portland Press Limited and the International Federation for Cell Biology are given the correct attributions. For more information, see Opt2Pay FAQs.

5. Journal features

5.1 Immediate Publications

PDFs of author manuscripts are mounted on the Journal's website as Cell Biology International Immediate Publications as soon as they are accepted, unless on submission you have requested that this not be done. Cell Biology International Immediate Publications are listed in and accessible through PubMed. Cell Biology International Reports Immediate Publications are mounted on the Journal's website as soon as the open-access publication fee has been received, unless on submission you have requested that this not be done.

5.2 Multimedia adjuncts

Cell Biology International Online offers authors the opportunity to enhance their papers with multimedia adjuncts (e.g. time-lapse movies, three-dimensional structures). These will be submitted to peer review along with the manuscript. To submit a paper with a multimedia adjunct, attach the file when you submit your manuscript online. Preferred formats are AVI, SWF, MPEG, QT and MOV for time-lapse movies, PDB for structures and Flash for animated schemes. There is no extra charge associated with the publication of a multimedia adjunct online.

5.3 Supplementary data

As a service to authors, additional data (e.g. large tables or datasets) that may be of interest to readers can be published in the online journal (the journal of record) only where they are made freely available via a link from the abstract and paper. It is essential, however, that these data are not critical to the understanding of the paper and that the paper can stand alone.

Supplementary data must be supplied for the review process, be cited in a relevant place in the text of the paper and be accompanied by a title and a self-explanatory legend. Offprints of papers will not contain Supplementary data.

5.4 Medline links and inter-journal linking

Cell Biology International provides links to Medline citations, to related papers in Medline, to Medline citations for downloading to citation management software, and from references to the relevant abstracts in other online journals.

6. Submission of papers

Important information for authors:
From 1 January 2013 Cell Biology International will be published by Wiley-Blackwell. Manuscripts should now be submitted at http://mc.manuscriptcentral.com/cbin

Submission checklist:

  • Covering letter
  • Master electronic copy of typescript, as a Word file:
    • complete text in appropriate style, pages numbered
    • full names and addresses of authors
    • full name, address, telephone and fax numbers and email address of corresponding author (all correspondence and proofs will be sent to this author)
    • figures
  • Multimedia adjuncts
  • Supplementary material (e.g. large data sets)
  • Related papers in press or under editorial consideration
  • Evidence of approval of personal communications
  • Evidence of submission of nucleic acid or protein sequences to an appropriate data bank.

You may specify the names of those reviewers you wish to have excluded from the review process for a particular paper; in such cases your wishes will usually be respected, unless, of course, in the opinion of the journal such a request unreasonably excludes all the expertise available to it in that scientific area.

7. Format of manuscript

Your manuscript should be written in clear, concise, and grammatically correct International English; manuscripts that are inadequately prepared in the required format of the journal will be declined, since it is not feasible for the Editors to undertake extensive revision or rewriting of manuscripts.

Title page: this should contain the following:

  • article title
  • name(s) of author(s) (with first or second given name spelled out in full)
  • author affiliation(s)
  • short running title (abbreviated form of title) of less than 45 characters including spaces
  • name and complete mailing address (including telephone and fax numbers and email address) of the person to whom correspondence should be sent
  • up to six key words (in alphabetical order), of which at least three do not appear in the title of the paper
  • list of abbreviations used (no need to list standard abbreviations such as DNA, RNA etc; use SI units wherever possible)
  • any footnotes

Abstract (maximum 250 words; no subheadings, not included in section numbering): this must be concise and factual, and able to stand alone

Subdivision: divide your paper into clearly defined and numbered sections. Subsections should be numbered 1.1 (then 1.1.1, 1.1.2, etc).

Introduction: the objectives of the work should be stated and an adequate background provided; avoid a detailed literature survey or a summary of the results.

Materials and methods (or Experimental): provide sufficient detail to allow the work to be reproduced; methods already published should be indicated by a reference and only relevant modifications described

Results: this section should be clear and concise, and may be combined with the Discussion section if appropriate

Discussion: this section should explore the significance of the results, not repeat them; extensive citations and discussion of published literature should be avoided

Conclusions: the main conclusions may be presented in this short section, which may stand alone or form a subsection of the Discussion section

Acknowledgements: list those individuals who provided assistance during the research or provided help with the writing of the article

Funding: in the form of a sentence with the full name of the funding agency followed by the grant number in square brackets

References should be cited within the text as follows:

  • One or two authors: (Smith, 2007); (Schenk and Matteoli, 2008)
  • More than two authors: (Jones et al., 2006)
  • If style requires, the format Jones et al. (2006) is also acceptable
  • Multiple dates, same author(s): (Smith et al., 2005a, 2005b)
  • In date order: (Zhou et al., 1999; Ari et al., 2004)

In the reference list, references should appear in alphabetical order by first author's last name. Include all authors' names (do not use "et al."), year, complete article title, journal, volume and inclusive page numbers. Abbreviate journal names according to PubMed; spell out the names of unlisted journals. Do not list unpublished material but cite parenthetically within the text as "unpublished data". Do not use others forms such as "manuscript in preparation," "manuscript submitted," "unpublished results" or "unpublished observation". Unpublished data may not be cited in the Materials and methods section. Unpublished data provided by a person(s) who is not an author of the article must be cited as a "personal communication". An authorization from this person(s) must be provided with the manuscript.

Adhere to the reference formats provided by the following examples:

Journal article

Jena BP. Molecular machinery and mechanism of cell secretion. Exp Biol Med
2005;230:307–19.

Dardalhon V, Ge´minard C, Reggio H, Vidal M, Sainte-Marie J. Fractionation
analysis of the endosomal compartment during rat reticulocyte maturation.
Cell Biol Int 2002;26:669–78.

Schraufstatter IU, Chung J, Burger M. IL-8 activates endothelial cell CXCR1
and CXCR2 through Rho and Rac signaling pathways. Am J Physiol Lung
Cell Mol Physiol 2001;280(6):L1094–103.

More than six authors

Cho RJ, Campbell MJ, Winzeler EA, Steinmetz L, Conway A, Wodicka L,
et al. A genome-wide transcriptional analysis of the mitotic cell cycle. Mol
Cell 1998;2:65–73.

Journal article in press

Gerashchenko MV, Chernoivanenko IS, Moldaver MV and Minin AA. Dynein is a motor for nuclear rotation while vimentin IFs is a "brake". Cell Biol Int 2009; doi: doi:10.1016/j.cellbi.2009.06.020

Complete book

Cooper S. Bacterial growth and division. San Diego, CA: Academic Press;
1991.

Chapter in book

Nelson DK, Malfertheiner P, Dahmen G, Dominguez-Munoz JE, Pieramico O,
Adler G. Regulation of exocrine and endocrine pathways via M1-muscarinic
pathways. In: Singer MV, Ziegler R, Rohr G, editors. Gastrointestinal
tract and endocrine system. Dordrecht: Kluwer; 1995. p. 570–74.

References are often the cause of many proof corrections, and inaccuracies hamper inter-journal linking and Medline links in the journal. Please check the list carefully before submission.

WWW URLs are permitted in the text only, not in the reference list, and should be quoted only when a literature reference(s) will not suffice.

Tables

Tables should be numbered with arabic numerals (Table 1, Table 2, etc.) and cited consecutively in the text. Each table should have a title and an explanatory legend. Units must be clearly indicated for each of the entries in the table. Footnotes to tables should be identified by superscript lower-case roman letters and placed at the bottom of the table.

Figures

Figures should be cited consecutively in the text by arabic numerals (Figure 1, Figure 2, etc.). Each figure should have a title and an explanatory legend. A 4:3 ratio is preferred for the area of figures.

8. Accepted papers

On acceptance the Production Office will ask you to supply a Word file of the final version of your paper. You must ensure that the file has been updated to incorporate all revisions, and hence that file matches the final version of the manuscript seen by the reviewers. Our preferred word-processing format is Word for Windows version 6.

8.1 Tables

Your tables should be prepared using the Microsoft Word table editor.

8.2 Figures

No artwork should be incorporated into the text files. Figures should be supplied as electronic files. Full instructions will be provided on acceptance and guidance notes for the preparation of figures are available, here. Lettering on the figures should be of a size that allows for appropriate reduction of the figures. There is no charge for colour figures provided they are necessary to convey scientific meaning.

Image acquisition and manipulation

Images will be checked for manipulation when a paper is accepted. The Editorial Board may request that you supply the original data for comparison against the prepared figures. If you are unable to comply with such a request, the acceptance of the paper may be withdrawn.

Cell Biology International endorses the guidelines given in the Instructions for Authors of the Journal for Cell Biology, from where the following is adapted by kind permission of Rockefeller University Press:

The following information must be provided about the acquisition and processing of images:

  1. Make and model of microscope
  2. Type, magnification and numerical aperture of the objective lenses
  3. Temperature
  4. Imaging medium
  5. Fluorochromes
  6. Camera make and model
  7. Acquisition software
  8. Any subsequent software used for image processing, with details about types of operations involved (e.g. type of deconvolution, 3D reconstructions, surface or volume rendering, gamma adjustments, etc.).

No specific feature within an image may be enhanced, obscured, moved, removed or introduced. The grouping of images from different parts of the same gel, or from different gels, fields or exposures must be made explicit by the arrangement of the figure (i.e. using dividing lines) and in the text of the figure legend. Adjustments of brightness, contrast or colour balance are acceptable if they are applied to the whole image and as long as they do not obscure, eliminate or misrepresent any information present in the original, including backgrounds.The background of figures should be clearly distinct from the surrounding page. Non-linear adjustments (e.g. changes to gamma settings) must be disclosed in the figure legend.

You are encouraged to read the papers by M. Rossner and K. M. Yamada (2004) J. Cell Biol. 166, 11-15 and A. J. North (2006) J.Cell Biol. 172, 9-18

8.3 Mathematics

In-line equations should be typed as text. Displayed equations (unless prepared by the 'MathType Equation Editor') are re-keyed by our typesetter.

9. Contact details

  • Correspondence about papers in review should be sent to:

    Angela Panther, Managing Editor
    Cell Biology International Editorial Office
    Portland Press Limited
    Third floor
    Charles Darwin House
    12 Roger Street
    London WC1N 2JU

    Email: editorial@cellbiolint.org
  • Correspondence about accepted papers, offprints and permissions should be sent to:

    Clare Curtis, Executive Editor
    Cell Biology International Production Office
    Portland Press Limited
    Third floor
    Charles Darwin House
    12 Roger Street
    London WC1N 2JU

    Telephone: +44 20 7685 2410
    Fax: +44 20 7685 2469
    Email: publisher@cellbiolint.org

10. Proofs

Proofs will be sent to you by email as a PDF, together with an offprint order form. Please note that you will be charged for extensive alterations. To avoid delay in publication, your corrected proofs should be faxed to the Production Office within 48 hours of receipt.

11. Offprints

You may purchase offprints at the prices given on the order form sent with the proofs.

12. Portland Press books

Authors, Editors and all contributors to Portland Press journals may order books published by Portland Press, for their personal use, at 25% discount. A complete list of books can be found at http://www.portlandpress.com.

© Portland Press Limited, London 2014


ISSN Print: 1065-6995
ISSN Electronic: 1095-8355
Published by Portland Press Limited on behalf of the International Federation for Cell Biology (IFCB)